title: E-selectin modulates the malignant properties of T84 colon carcinoma cells.
abstract: The extravasation of metastatic cells is regulated by molecular events involving the initial adhesion of tumor cells to the endothelium and subsequently the migration of cells in the host connective tissue. E-selectin on endothelial cells and sialyl Lewis X carbohydrate component on tumor cells are mainly involved in the adhesion of colon carcinoma cells to the endothelium of target organ. Interaction of T84 colon cancer cells to purified E-selectin in vitro caused an increase in the tyrosine phosphorylation of a number of proteins as well as the modulation of cellular properties correlated to the metastatic phenotype. Specifically, E-selectin-stimulated actin reorganization, increased collagenase secretion, and induced cell migration. Treatment of T84 cells with herbimycin A inhibited cell adhesion as well as selectin-induced increase of cell migration, and cytoskeleton assembly. Our data demonstrate that binding of cancer cells to E-selectin starts signal transduction pathways which may affect the tumor metastatic abilities.
authors.affiliation: Section of Biology and Genetics, Department of Biopathology and Biomedical Methodology, University of Palermo, Palermo, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Flugy
authors.forename: M
authors.initials: M
authors.lastname: D'Amato
authors.forename: D
authors.initials: D
authors.lastname: Russo
authors.forename: M A
authors.initials: MA
authors.lastname: Di Bella
authors.forename: G
authors.initials: G
authors.lastname: Alaimo
authors.forename: E C
authors.initials: EC
authors.lastname: Kohn
authors.forename: G
authors.initials: G
authors.lastname: De Leo
authors.forename: R
authors.initials: R
authors.lastname: Alessandro
mesh_terms: D016227:Benzoquinones; D002277:Carcinoma / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement; D002478:Cells, Cultured; D018920:Coculture Techniques; D003110:Colonic Neoplasms / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D019040:E-Selectin / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D047029:Lactams, Macrocyclic; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D009362:Neoplasm Metastasis; D009844:Oligosaccharides / Q000502:physiology; D010750:Phosphoproteins / Q000378:metabolism; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011809:Quinones / Q000494:pharmacology; D017828:Rifabutin / Q000031:analogs & derivatives; D000080506:Sialyl Lewis X Antigen; D014407:Tumor Cells, Cultured
chemical_list: D016227:Benzoquinones; D019040:E-Selectin; D004791:Enzyme Inhibitors; D047029:Lactams, Macrocyclic; D009844:Oligosaccharides; D010750:Phosphoproteins; D011809:Quinones; D000080506:Sialyl Lewis X Antigen; D017828:Rifabutin; D019000:Phosphotyrosine; C020754:herbimycin; D011505:Protein-Tyrosine Kinases; D020778:Matrix Metalloproteinase 2